These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8619692)

  • 21. Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery.
    Kreisler KR; Vance RA; Cruzzavala J; Mahnken JD
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):608-11. PubMed ID: 16202894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fulminant myocarditis treated with percutaneous cardiopulmonary support and long-term complications: three case reports].
    Kusaba T; Nakahara Y; Matsumuro A; Nakamura T; Sawada S
    J Cardiol; 2004 Apr; 43(4):185-91. PubMed ID: 15125383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin resistance and antithrombin: should it still be called heparin resistance?
    Levy JH
    J Cardiothorac Vasc Anesth; 2004 Apr; 18(2):129-30. PubMed ID: 15073697
    [No Abstract]   [Full Text] [Related]  

  • 25. Mitral valve repair and cardiac transplantation in a patient with factor XII deficiency.
    Veronesi R; Maurelli M; Bianchi T; Toscani M; Via G; Villani MA; Pettinella S; Santambrogio LG; Fuardo M
    J Cardiothorac Vasc Anesth; 2005 Jun; 19(3):419-20. PubMed ID: 16130082
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful anticoagulation with fresh frozen plasma for cardiopulmonary bypass in a patient with heparin resistance: a cautionary tale.
    Badrin O; Kushairi S; Zakaria Z; Sachithanandan A
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23632185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiopulmonary support in the intensive care unit.
    Pritchard GL
    Am J Crit Care; 1993 Jan; 2(1):100-1. PubMed ID: 8353573
    [No Abstract]   [Full Text] [Related]  

  • 28. Another perspective on monitoring anticoagulation therapy.
    Burnakis TG
    Ann Pharmacother; 1995 Oct; 29(10):1045-6. PubMed ID: 8845545
    [No Abstract]   [Full Text] [Related]  

  • 29. Monitoring anticoagulation of patients with antiphospholipid antibodies on cardiopulmonary bypass.
    Naggs TA
    J Cardiothorac Vasc Anesth; 2010 Aug; 24(4):734-5. PubMed ID: 19640745
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticoagulation management during cardiopulmonary bypass: a survey of 54 North American institutions.
    Lobato RL; Despotis GJ; Levy JH; Shore-Lesserson LJ; Carlson MO; Bennett-Guerrero E
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1665-6. PubMed ID: 20303507
    [No Abstract]   [Full Text] [Related]  

  • 31. Factor XII deficiency and cardiopulmonary bypass: use of a novel modification of the activated clotting time to monitor anticoagulation.
    Gerhardt MA; Greenberg CS; Slaughter TF; Stafford Smith M
    Anesthesiology; 1997 Oct; 87(4):990-2. PubMed ID: 9357906
    [No Abstract]   [Full Text] [Related]  

  • 32. Intrinsic pathway-dependent activated clotting time is not reliable for monitoring anticoagulation during cardiopulmonary bypass in neonates.
    Gu YJ; Huyzen RJ; van Oeveren W
    J Thorac Cardiovasc Surg; 1996 Mar; 111(3):677-8. PubMed ID: 8601987
    [No Abstract]   [Full Text] [Related]  

  • 33. Urban myths and the ACT: what is not true and what really matters when it comes to monitoring anticoagulation.
    Searles B
    J Extra Corpor Technol; 2006 Mar; 38(1):56-8. PubMed ID: 16637527
    [No Abstract]   [Full Text] [Related]  

  • 34. Point-of-care coagulation monitoring for cardiovascular patients: past and present.
    Shore-Lesserson L
    J Cardiothorac Vasc Anesth; 2002 Feb; 16(1):99-106. PubMed ID: 11854887
    [No Abstract]   [Full Text] [Related]  

  • 35. Is the activated clotting time dangerous?
    Metz S
    Anesthesiology; 2005 Oct; 103(4):903-4; author reply 904. PubMed ID: 16192793
    [No Abstract]   [Full Text] [Related]  

  • 36. It is a tough "ACT" to follow.
    Jobes DR
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):393-4. PubMed ID: 21621157
    [No Abstract]   [Full Text] [Related]  

  • 37. Monitoring of the electroencephalogram during cardiopulmonary bypass. Know when to say when.
    Levy WJ
    Anesthesiology; 1992 Jun; 76(6):876-7. PubMed ID: 1599108
    [No Abstract]   [Full Text] [Related]  

  • 38. Heparin resistance during cardiopulmonary bypass.
    Hicks GL
    J Thorac Cardiovasc Surg; 1983 Oct; 86(4):633. PubMed ID: 6621092
    [No Abstract]   [Full Text] [Related]  

  • 39. Portable cardiopulmonary support (ECPS) in the emergency room.
    Ullrich R; Kneifel W; Fuchs M; Hödl W; Zimpfer M; Germann P
    Anaesthesia; 1998 May; 53 Suppl 2():6-8. PubMed ID: 9659042
    [No Abstract]   [Full Text] [Related]  

  • 40. Heparin anticoagulation.
    Scheinberg P
    Stroke; 1989 Feb; 20(2):173-4. PubMed ID: 2919409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.